1. Home
  2. ACXP vs NUTX Comparison

ACXP vs NUTX Comparison

Compare ACXP & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.65

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$147.01

Market Cap

912.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACXP
NUTX
Founded
2017
2011
Country
United States
United States
Employees
N/A
944
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
912.4M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
ACXP
NUTX
Price
$1.65
$147.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$95.50
$252.50
AVG Volume (30 Days)
84.5K
95.6K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.93
EPS
N/A
6.52
Revenue
N/A
$875,257,000.00
Revenue This Year
N/A
$6.12
Revenue Next Year
N/A
$4.04
P/E Ratio
N/A
$20.49
Revenue Growth
N/A
82.36
52 Week Low
$0.29
$77.21
52 Week High
$8.34
$193.07

Technical Indicators

Market Signals
Indicator
ACXP
NUTX
Relative Strength Index (RSI) 34.10 64.85
Support Level $1.37 $143.94
Resistance Level $2.26 $161.67
Average True Range (ATR) 0.12 8.35
MACD -0.00 0.90
Stochastic Oscillator 13.43 100.00

Price Performance

Historical Comparison
ACXP
NUTX

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

About NUTX Nutex Health Inc.

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

Share on Social Networks: